Conditions: Advanced Relapsed or Refractory Germ Cell Tumours; Advanced Relapsed or Refractory Endometrial Cancer; Advanced Relapsed or Refractory Ovarian Cancer
Interventions: Drug: BI 3820768
Sponsors: Boehringer Ingelheim
Not yet **RECRUITING NOW**
Interventions: Drug: BI 3820768
Sponsors: Boehringer Ingelheim
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
